We should expect to see new variants and vaccines for COVID-19 every year: Jason Kolbert
Jason Kolbert, senior healthcare analyst at Dawson James Securities, breaks down Omicron variant concerns and gives his take on where he sees value in healthcare stocks. Kolbert says that Omicron cases can overwhelm hospital systems and he understands the government measures being put in place, even if the mortality rate with this variant is lower. He talks on which healthcare stocks he thinks will be important in the future.